GleanMark

CBT MEDICINES Trademark

CBT MEDICINES is a USPTO trademark filed by Cellarity, Inc.. Status: Abandoned.

Trademark Facts

MarkCBT MEDICINES
Serial Number90239632
StatusAbandoned
Filing Date2020-10-07
Mark TypeWord
Nice Classes005 (Pharmaceuticals), 042 (Software & IT)
OwnerCellarity, Inc.
Attorney of RecordChristina M. Licursi
Prosecution Events45
Latest EventMAB6 on 2025-07-07

Goods & Services

Pharmaceuticals and therapeutics for the treatment of immunological diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders; none of the foregoing for use in the treatment of cancer; "MEDICINES"; Providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug analysis, namely, drug discovery and development; providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research

Related